Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137871) titled 'Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The University of Texas Health Science Center at San Antonio
Condition:
Breast Cancer Metastatic
Intervention:
Drug: Avasopasem
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2025
Target Sample Size: 35
Countries of Recruit...